greeksoup/ stock research
Stock research / United States / XERS / Planned sales

Xeris Biopharma Holdings, Inc. planned insider sales

In the last twelve months insiders at Xeris Biopharma Holdings, Inc. filed 18 Form 144 notices of planned sales, 790,885 shares worth $5.9 million at the time of filing, from 10 sellers. The latest, filed 1 October 2026: Beth Hecht (officer), 16,666 shares worth $159,327, planned for around 1 October 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
1 October 2026Beth HechtOfficer16,666$159,3271 October 202616,666 shares from 1 October 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesOpen Market Purchase; Restricted Stock UnitsForm 144
28 September 2026Kevin McCullochOfficer70,000$637,00028 September 202640,000 shares from 28 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
12 August 2026Steven PieperOfficer20,000$167,80012 August 202615,000 shares from 12 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
7 July 2026Steven PieperOfficer27,600$231,0127 July 202645,000 shares from 6 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesOpen Market Purchase; Restricted Stock UnitsForm 144
6 July 2026Steven PieperOfficer17,400$144,0726 July 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesOpen Market Purchase; Restricted Stock UnitsForm 144
1 July 2026Beth HechtOfficer49,998$395,9841 July 202649,998 shares from 1 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesEmployee Stock Purchase Plan; Open Market Purchase; Restricted Stock UnitsForm 144
1 July 2026Kevin McCullochOfficer120,000$950,4001 July 2026120,000 shares from 1 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
4 June 2026John H JohnsonDirector15,000$88,3504 June 202615,000 shares from 4 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
4 June 2026Barbara-Jean Bormann-KennedyDirector16,000$94,2404 June 202616,000 shares from 4 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
4 June 2026Dawn HalkuffDirector20,000$117,8004 June 202620,000 shares from 4 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
3 June 2026Marla PerskyDirector15,500$93,0003 June 202615,500 shares from 3 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 March 2026James BradyDirector10,834$58,50430 March 202610,834 shares from 30 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
2 March 2026Beth HechtOfficer66,668$408,0082 March 202650,001 shares from 2 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
8 January 2026Kevin McCullochOfficer60,000$432,6008 January 202615,000 shares from 8 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
19 December 2025John H JohnsonDirector135,402$977,03419 December 2025135,400 shares from 19 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
12 December 2025Barbara-Jean A Bormann-KennedyDirector15,000$105,15012 December 202515,000 shares from 12 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
13 November 2025John ShannonDirector, Officer48,149$365,45113 November 202548,149 shares from 13 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Restricted Stock UnitsForm 144
12 November 2025Beth HechtOfficer66,668$514,67711 November 202566,668 shares from 11 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?